InvestorsHub Logo

H2R

Followers 41
Posts 2214
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Friday, 02/25/2022 2:41:29 PM

Friday, February 25, 2022 2:41:29 PM

Post# of 1044
Hilzinger, Director: purchase 175k shares for $256,970



Insider Buy: Outlook Therapeutics
BY MT Newswires

05:45 PM EST, 02/23/2022 (MT Newswires) -- Kurt J Hilzinger, Director, on February 22, 2022, executed a purchase for 175,132 shares in Outlook Therapeutics ( OTLK) for $256,970. Following the Form 4 filing with the SEC, Hilzinger has control over a total of 198,249 shares of the company, with 198,249 shares held directly. The market value of the direct and indirect holding, based on the transaction price, is approximately $285,479.




SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649989/000120919122012325/xslF345X03/doc4.xml
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News